Phillips-Medisize Accelerates Growth with the Opening of a New Global Innovation and Development Office in Copenhagen, Denmark

Phillips-Medisize, a Molex company, announced the opening of a new Global Innovation and Development (GID) center in Copenhagen, Denmark to support long-term growth plans for its advanced injection, wearable devices and connected health technologies. The new center enables the company to accelerate creation of world-class and differentiated drug delivery devices for its global customer base, while providing an easily accessible hub for its European customers.

Copenhagen offers an optimal location from which to access top drug delivery and connectivity resources that complement existing Phillips-Medisize European centers in Struer, Denmark and Cambridge, UK.  By establishing a presence in Copenhagen, Phillips-Medisize is in the middle of the Medicon Valley cluster, close to top universities, hospitals and global R&D-based pharmaceutical and medical device companies. This Scandinavian region is a natural entry point into Europe and is home to innovators exploring large unmet medical needs in areas such as oncology, diabetes and personalized medicine.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report